A Citizens Panel on Pharmacare was held in Canada. From its webpage:
In October 2016, we invited 35 randomly selected Canadians to meet in Ottawa to consider whether there are better models that can improve access to prescription drugs.
Over five days, this group heard from a range of experts, examined different options, and, together, developed a clear set of recommendations for Canada’s health ministers and policy makers.
The panel’s report is here.
Note that although it says the 35 citizens are randomly selected, if you read further you can see that what they actually mean is that they were randomly selected from people who had volunteered to be on the panel. Some of the CBC news coverage of the report:
The panel’s research was funded by the Canadian Institutes of Health Research. A committee of clinicians, senior public servants and health researchers from across Canada oversaw the process.
[Emily] Dukeshire [of Calgary, one of the citizen panelists,] said she was impressed with the process. Panelists were randomly selected from about 1,000 representative people who had volunteered to take part in the process to advise policy-makers on drug coverage for Canadians.
“This whole process was really amazing that we were all so different and from all across the country, and yet we went through this process together and we were able to come up with core values that we all believed. We were able to define some issues and then come up with some solutions together,” Dukeshire said.
Other speakers included doctors, nurses, pharmacists, brand name and generic manufacturers, insurers, retailers, patients, public agencies, academics and former policy-makers.